BioCardia, Inc. Investment Income, Interest
BioCardia, Inc. (BCDA) reported Investment Income, Interest of $9.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2022-03-29
- BioCardia, Inc. investment income, interest for the quarter ending 2021-12-31 was $1.00K, a 50.00% decline year-over-year.
- BioCardia, Inc. investment income, interest for the quarter ending 2021-09-30 was $2.00K, a 100.00% increase year-over-year.
- BioCardia, Inc. investment income, interest for the quarter ending 2021-06-30 was $2.00K, a 0.00% change year-over-year.
- BioCardia, Inc. investment income, interest for the quarter ending 2021-03-31 was $4.00K.
- BioCardia, Inc. investment income, interest for fiscal 2021 was $9.00K, a 57.14% decline from fiscal 2020.
- BioCardia, Inc. investment income, interest for fiscal 2020 was $21.00K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2021-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $3.00K derived: sum of 2 quarters · filed 2022-03-29 | $5.00K derived: sum of 3 quarters · filed 2022-03-29 | $9.00K 10-K · filed 2022-03-29 |
| 2021-09-30 | $2.00K 10-Q · filed 2021-11-10 | $4.00K derived: sum of 2 quarters · filed 2021-11-10 | $8.00K 10-Q · filed 2021-11-10 | $10.00K derived: sum of 4 quarters · filed 2022-03-29 |
| 2021-06-30 | $2.00K 10-Q · filed 2021-08-12 | $6.00K 10-Q · filed 2021-08-12 | $8.00K derived: sum of 3 quarters · filed 2022-03-29 | $9.00K derived: sum of 4 quarters · filed 2022-03-29 |
| 2021-03-31 | $4.00K derived: 10-K 12 month − 3 quarters · filed 2022-03-29 | $6.00K derived: sum of 2 quarters · filed 2022-03-29 | $7.00K derived: sum of 3 quarters · filed 2022-03-29 | $9.00K derived: sum of 4 quarters · filed 2022-03-29 |
| 2020-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $3.00K derived: sum of 2 quarters · filed 2022-03-29 | $5.00K derived: sum of 3 quarters · filed 2022-03-29 | $21.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $1.00K 10-Q · filed 2021-11-10 | $3.00K derived: sum of 2 quarters · filed 2021-11-10 | $19.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $2.00K 10-Q · filed 2021-08-12 | $18.00K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |